Package 70518-4513-0

{"route": ["ORAL"], "spl_id": "42b0dc89-b6da-5a4b-e063-6394a90a56e4", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897640"], "spl_set_id": ["d7c29dfd-3968-41ac-a081-e670f9bd605c"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-4513-0)", "package_ndc": "70518-4513-0", "marketing_start_date": "20251101"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "70518-4513_42b0dc89-b6da-5a4b-e063-6394a90a56e4", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70518-4513", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20251101", "listing_expiration_date": "20261231"}